Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global CRISPR Nucleases market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CRISPR Cas3 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CRISPR Nucleases include Thermo Fisher, TriLink BioTechnologies, Qiagen, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Horizon Discovery Plc and Sigma Aldrich, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR Nucleases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Nucleases. This report contains market size and forecasts of CRISPR Nucleases in global, including the following market information:
Global CRISPR Nucleases Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CRISPR Nucleases companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR Nucleases Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global CRISPR Nucleases Market Segment Percentages, by Type, 2022 (%)
CRISPR Cas3
CRISPR Cas9
CRISPR Cas10
Others
Global CRISPR Nucleases Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global CRISPR Nucleases Market Segment Percentages, by Application, 2022 (%)
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Global CRISPR Nucleases Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global CRISPR Nucleases Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRISPR Nucleases revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CRISPR Nucleases revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher
TriLink BioTechnologies
Qiagen
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Horizon Discovery Plc
Sigma Aldrich
Genscript
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Aldevron
Takara Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of CRISPR Nucleases, market overview.
Chapter 2: Global CRISPR Nucleases market size in revenue.
Chapter 3: Detailed analysis of CRISPR Nucleases company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CRISPR Nucleases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 CRISPR Nucleases Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CRISPR Nucleases Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CRISPR Nucleases Overall Market Size
2.1 Global CRISPR Nucleases Market Size: 2022 VS 2029
2.2 Global CRISPR Nucleases Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CRISPR Nucleases Players in Global Market
3.2 Top Global CRISPR Nucleases Companies Ranked by Revenue
3.3 Global CRISPR Nucleases Revenue by Companies
3.4 Top 3 and Top 5 CRISPR Nucleases Companies in Global Market, by Revenue in 2022
3.5 Global Companies CRISPR Nucleases Product Type
3.6 Tier 1, Tier 2 and Tier 3 CRISPR Nucleases Players in Global Market
3.6.1 List of Global Tier 1 CRISPR Nucleases Companies
3.6.2 List of Global Tier 2 and Tier 3 CRISPR Nucleases Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CRISPR Nucleases Market Size Markets, 2022 & 2029
4.1.2 CRISPR Cas3
4.1.3 CRISPR Cas9
4.1.4 CRISPR Cas10
4.1.5 Others
4.2 By Type - Global CRISPR Nucleases Revenue & Forecasts
4.2.1 By Type - Global CRISPR Nucleases Revenue, 2018-2023
4.2.2 By Type - Global CRISPR Nucleases Revenue, 2024-2029
4.2.3 By Type - Global CRISPR Nucleases Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CRISPR Nucleases Market Size, 2022 & 2029
5.1.2 Biotechnology Companies
5.1.3 Pharmaceutical Companies
5.1.4 Academic Institutes
5.1.5 Research and Development Institutes
5.2 By Application - Global CRISPR Nucleases Revenue & Forecasts
5.2.1 By Application - Global CRISPR Nucleases Revenue, 2018-2023
5.2.2 By Application - Global CRISPR Nucleases Revenue, 2024-2029
5.2.3 By Application - Global CRISPR Nucleases Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global CRISPR Nucleases Market Size, 2022 & 2029
6.2 By Region - Global CRISPR Nucleases Revenue & Forecasts
6.2.1 By Region - Global CRISPR Nucleases Revenue, 2018-2023
6.2.2 By Region - Global CRISPR Nucleases Revenue, 2024-2029
6.2.3 By Region - Global CRISPR Nucleases Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America CRISPR Nucleases Revenue, 2018-2029
6.3.2 US CRISPR Nucleases Market Size, 2018-2029
6.3.3 Canada CRISPR Nucleases Market Size, 2018-2029
6.3.4 Mexico CRISPR Nucleases Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe CRISPR Nucleases Revenue, 2018-2029
6.4.2 Germany CRISPR Nucleases Market Size, 2018-2029
6.4.3 France CRISPR Nucleases Market Size, 2018-2029
6.4.4 U.K. CRISPR Nucleases Market Size, 2018-2029
6.4.5 Italy CRISPR Nucleases Market Size, 2018-2029
6.4.6 Russia CRISPR Nucleases Market Size, 2018-2029
6.4.7 Nordic Countries CRISPR Nucleases Market Size, 2018-2029
6.4.8 Benelux CRISPR Nucleases Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia CRISPR Nucleases Revenue, 2018-2029
6.5.2 China CRISPR Nucleases Market Size, 2018-2029
6.5.3 Japan CRISPR Nucleases Market Size, 2018-2029
6.5.4 South Korea CRISPR Nucleases Market Size, 2018-2029
6.5.5 Southeast Asia CRISPR Nucleases Market Size, 2018-2029
6.5.6 India CRISPR Nucleases Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America CRISPR Nucleases Revenue, 2018-2029
6.6.2 Brazil CRISPR Nucleases Market Size, 2018-2029
6.6.3 Argentina CRISPR Nucleases Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CRISPR Nucleases Revenue, 2018-2029
6.7.2 Turkey CRISPR Nucleases Market Size, 2018-2029
6.7.3 Israel CRISPR Nucleases Market Size, 2018-2029
6.7.4 Saudi Arabia CRISPR Nucleases Market Size, 2018-2029
6.7.5 UAE CRISPR Nucleases Market Size, 2018-2029
7 CRISPR Nucleases Companies Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Summary
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher CRISPR Nucleases Major Product Offerings
7.1.4 Thermo Fisher CRISPR Nucleases Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Key News & Latest Developments
7.2 TriLink BioTechnologies
7.2.1 TriLink BioTechnologies Company Summary
7.2.2 TriLink BioTechnologies Business Overview
7.2.3 TriLink BioTechnologies CRISPR Nucleases Major Product Offerings
7.2.4 TriLink BioTechnologies CRISPR Nucleases Revenue in Global Market (2018-2023)
7.2.5 TriLink BioTechnologies Key News & Latest Developments
7.3 Qiagen
7.3.1 Qiagen Company Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen CRISPR Nucleases Major Product Offerings
7.3.4 Qiagen CRISPR Nucleases Revenue in Global Market (2018-2023)
7.3.5 Qiagen Key News & Latest Developments
7.4 Editas Medicine
7.4.1 Editas Medicine Company Summary
7.4.2 Editas Medicine Business Overview
7.4.3 Editas Medicine CRISPR Nucleases Major Product Offerings
7.4.4 Editas Medicine CRISPR Nucleases Revenue in Global Market (2018-2023)
7.4.5 Editas Medicine Key News & Latest Developments
7.5 Caribou Biosciences
7.5.1 Caribou Biosciences Company Summary
7.5.2 Caribou Biosciences Business Overview
7.5.3 Caribou Biosciences CRISPR Nucleases Major Product Offerings
7.5.4 Caribou Biosciences CRISPR Nucleases Revenue in Global Market (2018-2023)
7.5.5 Caribou Biosciences Key News & Latest Developments
7.6 CRISPR therapeutics
7.6.1 CRISPR therapeutics Company Summary
7.6.2 CRISPR therapeutics Business Overview
7.6.3 CRISPR therapeutics CRISPR Nucleases Major Product Offerings
7.6.4 CRISPR therapeutics CRISPR Nucleases Revenue in Global Market (2018-2023)
7.6.5 CRISPR therapeutics Key News & Latest Developments
7.7 Intellia therapeutics, Inc.
7.7.1 Intellia therapeutics, Inc. Company Summary
7.7.2 Intellia therapeutics, Inc. Business Overview
7.7.3 Intellia therapeutics, Inc. CRISPR Nucleases Major Product Offerings
7.7.4 Intellia therapeutics, Inc. CRISPR Nucleases Revenue in Global Market (2018-2023)
7.7.5 Intellia therapeutics, Inc. Key News & Latest Developments
7.8 Horizon Discovery Plc
7.8.1 Horizon Discovery Plc Company Summary
7.8.2 Horizon Discovery Plc Business Overview
7.8.3 Horizon Discovery Plc CRISPR Nucleases Major Product Offerings
7.8.4 Horizon Discovery Plc CRISPR Nucleases Revenue in Global Market (2018-2023)
7.8.5 Horizon Discovery Plc Key News & Latest Developments
7.9 Sigma Aldrich
7.9.1 Sigma Aldrich Company Summary
7.9.2 Sigma Aldrich Business Overview
7.9.3 Sigma Aldrich CRISPR Nucleases Major Product Offerings
7.9.4 Sigma Aldrich CRISPR Nucleases Revenue in Global Market (2018-2023)
7.9.5 Sigma Aldrich Key News & Latest Developments
7.10 Genscript
7.10.1 Genscript Company Summary
7.10.2 Genscript Business Overview
7.10.3 Genscript CRISPR Nucleases Major Product Offerings
7.10.4 Genscript CRISPR Nucleases Revenue in Global Market (2018-2023)
7.10.5 Genscript Key News & Latest Developments
7.11 Integrated DNA Technologies
7.11.1 Integrated DNA Technologies Company Summary
7.11.2 Integrated DNA Technologies Business Overview
7.11.3 Integrated DNA Technologies CRISPR Nucleases Major Product Offerings
7.11.4 Integrated DNA Technologies CRISPR Nucleases Revenue in Global Market (2018-2023)
7.11.5 Integrated DNA Technologies Key News & Latest Developments
7.12 New England Biolabs
7.12.1 New England Biolabs Company Summary
7.12.2 New England Biolabs Business Overview
7.12.3 New England Biolabs CRISPR Nucleases Major Product Offerings
7.12.4 New England Biolabs CRISPR Nucleases Revenue in Global Market (2018-2023)
7.12.5 New England Biolabs Key News & Latest Developments
7.13 Origene Technologies
7.13.1 Origene Technologies Company Summary
7.13.2 Origene Technologies Business Overview
7.13.3 Origene Technologies CRISPR Nucleases Major Product Offerings
7.13.4 Origene Technologies CRISPR Nucleases Revenue in Global Market (2018-2023)
7.13.5 Origene Technologies Key News & Latest Developments
7.14 Aldevron
7.14.1 Aldevron Company Summary
7.14.2 Aldevron Business Overview
7.14.3 Aldevron CRISPR Nucleases Major Product Offerings
7.14.4 Aldevron CRISPR Nucleases Revenue in Global Market (2018-2023)
7.14.5 Aldevron Key News & Latest Developments
7.15 Takara Bio
7.15.1 Takara Bio Company Summary
7.15.2 Takara Bio Business Overview
7.15.3 Takara Bio CRISPR Nucleases Major Product Offerings
7.15.4 Takara Bio CRISPR Nucleases Revenue in Global Market (2018-2023)
7.15.5 Takara Bio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
